X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9847) 9847
Book Review (813) 813
Publication (387) 387
Newsletter (82) 82
Book Chapter (14) 14
Conference Proceeding (12) 12
Book / eBook (6) 6
Dissertation (3) 3
Magazine Article (2) 2
Newspaper Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (8845) 8845
humans (7144) 7144
bleomycin - administration & dosage (5607) 5607
male (5421) 5421
female (4184) 4184
antineoplastic combined chemotherapy protocols - therapeutic use (3790) 3790
adult (3561) 3561
bleomycin (3521) 3521
middle aged (3271) 3271
animals (2660) 2660
cisplatin - administration & dosage (2338) 2338
aged (2176) 2176
oncology (2138) 2138
doxorubicin - administration & dosage (2036) 2036
vincristine - administration & dosage (1858) 1858
mice (1699) 1699
chemotherapy (1539) 1539
combined modality therapy (1525) 1525
adolescent (1517) 1517
bleomycin - adverse effects (1482) 1482
cyclophosphamide - administration & dosage (1473) 1473
vinblastine - administration & dosage (1433) 1433
etoposide - administration & dosage (1425) 1425
antineoplastic combined chemotherapy protocols - adverse effects (1220) 1220
prednisone - administration & dosage (1169) 1169
treatment outcome (1155) 1155
bleomycin - therapeutic use (1109) 1109
abridged index medicus (1091) 1091
antineoplastic combined chemotherapy protocols - administration & dosage (1054) 1054
cancer (1043) 1043
pulmonary fibrosis - chemically induced (1017) 1017
methotrexate - administration & dosage (1000) 1000
pulmonary fibrosis (971) 971
hodgkin disease - drug therapy (933) 933
prognosis (920) 920
neoplasm staging (887) 887
respiratory system (844) 844
testicular neoplasms - drug therapy (839) 839
carcinoma, squamous cell - drug therapy (819) 819
rats (802) 802
follow-up studies (799) 799
fibrosis (769) 769
dacarbazine - administration & dosage (752) 752
lung - pathology (723) 723
drug administration schedule (691) 691
time factors (672) 672
remission induction (668) 668
pulmonary fibrosis - pathology (658) 658
mice, inbred c57bl (657) 657
procarbazine - administration & dosage (655) 655
bleomycin - toxicity (644) 644
cisplatin (644) 644
survival rate (615) 615
drug therapy, combination (613) 613
child (611) 611
lung - drug effects (604) 604
disease models, animal (603) 603
retrospective studies (547) 547
antineoplastic agents - administration & dosage (545) 545
inflammation (545) 545
disease (540) 540
therapy (539) 539
hematology (527) 527
bleomycin - pharmacology (525) 525
pharmacology & pharmacy (498) 498
expression (494) 494
lung - metabolism (492) 492
antibiotics, antineoplastic - administration & dosage (485) 485
vinblastine (483) 483
disease-free survival (478) 478
pulmonary fibrosis - metabolism (473) 473
survival analysis (470) 470
prospective studies (467) 467
radiotherapy (467) 467
care and treatment (464) 464
cisplatin - adverse effects (459) 459
dose-response relationship, drug (451) 451
lymphoma, non-hodgkin - drug therapy (450) 450
surgery (436) 436
doxorubicin - adverse effects (428) 428
collagen (427) 427
research (423) 423
neoplasms, germ cell and embryonal - drug therapy (421) 421
hodgkin disease - pathology (404) 404
aged, 80 and over (403) 403
fluorouracil - administration & dosage (396) 396
lung (396) 396
tumors (393) 393
head and neck neoplasms - drug therapy (389) 389
cell biology (385) 385
lung diseases (385) 385
respiratory tract diseases (378) 378
etoposide (377) 377
mechlorethamine - administration & dosage (377) 377
testicular neoplasms - pathology (376) 376
analysis (374) 374
cells (372) 372
combination chemotherapy (371) 371
hodgkin disease - radiotherapy (368) 368
vincristine - adverse effects (364) 364
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8324) 8324
Japanese (756) 756
German (202) 202
French (178) 178
Chinese (147) 147
Russian (95) 95
Spanish (69) 69
Polish (64) 64
Italian (31) 31
Hungarian (16) 16
Dutch (9) 9
Portuguese (9) 9
Hebrew (8) 8
Korean (7) 7
Czech (5) 5
Bulgarian (4) 4
Finnish (3) 3
Lithuanian (3) 3
Norwegian (3) 3
Romanian (3) 3
Turkish (3) 3
Croatian (2) 2
Danish (2) 2
Serbian (2) 2
Afrikaans (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 04/2016, Volume 34, Issue 11, pp. 1175 - 1181
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2016, Volume 34, Issue 17, pp. 2020 - 2027
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 12, pp. 1188 - 1194
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2017, Volume 35, Issue 16, pp. 1786 - 1794
Journal Article
British Journal of Haematology, ISSN 0007-1048, 05/2014, Volume 165, Issue 4, pp. 534 - 544
The purpose of this national retrospective study was to evaluate the outcome in children with relapsed or primary refractory Hodgkin lymphoma [ HL ] after a... 
refractory disease | relapse | children | odgkin lymphoma | survival | Relapse | Children | Refractory disease | Survival | Hodgkin lymphoma | COMBINED-MODALITY THERAPY | PROGNOSTIC-FACTORS | RADIATION | CHEMOTHERAPY | TRIAL | FRENCH SOCIETY | DISEASE | SALVAGE THERAPY | RADIOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Procarbazine - administration & dosage | Prednisolone - adverse effects | Recurrence | Cyclophosphamide - administration & dosage | Prednisolone - administration & dosage | Follow-Up Studies | Humans | Vinblastine - administration & dosage | Cyclophosphamide - adverse effects | Hodgkin Disease - surgery | Hodgkin Disease - mortality | Vincristine - administration & dosage | Child | Dacarbazine - administration & dosage | Dexamethasone - administration & dosage | Hematopoietic Stem Cell Transplantation | Etoposide - administration & dosage | Combined Modality Therapy | Bleomycin - administration & dosage | Remission Induction | Cytarabine - administration & dosage | Ifosfamide - administration & dosage | Adolescent | Vincristine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Epirubicin - administration & dosage | Cisplatin - administration & dosage | Hodgkin Disease - radiotherapy | Multicenter Studies as Topic | Hodgkin Disease - drug therapy | Retrospective Studies | Radiotherapy, Adjuvant | Doxorubicin - administration & dosage | Chlorambucil - administration & dosage | Prednisone - administration & dosage | Etoposide - adverse effects | Ifosfamide - adverse effects | Kaplan-Meier Estimate | Treatment Outcome | Clinical Trials as Topic | Disease-Free Survival | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Carmustine - administration & dosage | Patient outcomes | Diseases | Index Medicus
Journal Article
Annals of Oncology, ISSN 0923-7534, 03/2011, Volume 22, Issue 3, pp. 664 - 670
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2010, Volume 28, Issue 27, pp. 4199 - 4206
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 3, pp. 163 - 168
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2012, Volume 30, Issue 9, pp. 907 - 913
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2013, Volume 31, Issue 2, pp. 231 - 239
Purpose To optimize fertility advice in patients with Hodgkin lymphoma (HL) before therapy and during survivorship, information on the impact of chemotherapy... 
INHIBIN-B | PRESERVATION | OUTCOME MEASURE | OVARIAN RESERVE | ONCOLOGY | TERM FOLLOW-UP | DISEASE | FEMALE CANCER SURVIVORS | ANTI-MULLERIAN HORMONE | CHEMOTHERAPY | SERUM MARKER | Procarbazine - administration & dosage | Cyclophosphamide - administration & dosage | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - administration & dosage | Cyclophosphamide - adverse effects | Gonadotropin-Releasing Hormone - analogs & derivatives | Fertility - physiology | Fertility Preservation | Young Adult | Vinblastine - adverse effects | Follicle Stimulating Hormone - blood | Hodgkin Disease - drug therapy | Oligospermia - epidemiology | Vincristine - administration & dosage | Adult | Female | Gonadotropin-Releasing Hormone - therapeutic use | Hodgkin Disease - physiopathology | Inhibins - blood | Menstrual Cycle - drug effects | Testosterone - blood | Menstrual Cycle - physiology | Doxorubicin - administration & dosage | Dacarbazine - administration & dosage | Prednisone - administration & dosage | Etoposide - adverse effects | Prednisone - adverse effects | Survivors | Etoposide - administration & dosage | Ovary - physiology | Hodgkin Disease - epidemiology | Bleomycin - administration & dosage | Bleomycin - adverse effects | Germany - epidemiology | Randomized Controlled Trials as Topic | Pregnancy | Testis - physiology | Hodgkin Disease - blood | Procarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - adverse effects | Doxorubicin - adverse effects | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2005, Volume 23, Issue 36, pp. 9198 - 9207
Journal Article
British Journal of Haematology, ISSN 0007-1048, 10/2010, Volume 151, Issue 2, pp. 159 - 166
Peripheral T-Cell lymphomas (PTCL) are relatively rare diseases but appear to be highly aggressive and display worse remission and survival rates than B-cell... 
cyclophosphamide | clinical trials | vincristine | doxorubicin | prednisone (CHOP) | T-cell lymphoma | NON-HODGKINS-LYMPHOMAS | CLASSIFICATION | IFOSFAMIDE | CHEMOTHERAPY | TRANSPLANTATION | ETOPOSIDE | THERAPY | PROGNOSTIC-SIGNIFICANCE | HEMATOLOGY | Cyclophosphamide - administration & dosage | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - administration & dosage | Cyclophosphamide - adverse effects | Cisplatin - administration & dosage | Young Adult | Vinblastine - adverse effects | Vincristine - administration & dosage | Adult | Female | Doxorubicin - administration & dosage | Dacarbazine - administration & dosage | Lymphoma, T-Cell, Peripheral - drug therapy | Prednisone - administration & dosage | Etoposide - adverse effects | Prednisone - adverse effects | Ifosfamide - adverse effects | Etoposide - administration & dosage | Treatment Outcome | Bleomycin - administration & dosage | Bleomycin - adverse effects | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, T-Cell, Peripheral - pathology | Adolescent | Survival Analysis | Cisplatin - adverse effects | Vincristine - adverse effects | Aged | Neoplasm Staging | Doxorubicin - adverse effects | Anthracyclines | Cyclophosphamide | Corticosteroids | Etoposide | Clinical trials | Product development | Prednisone | Non-Hodgkin's lymphomas | T cells | double prime B-cell lymphoma | Cell survival | Vinblastine | Ifosfamide | Toxicity | Doxorubicin | Survival | Vincristine | Cisplatin | Dacarbazine | Bleomycin | Remission | double prime T-cell lymphoma | Anaplastic large-cell lymphoma | expressed sequence tags | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 11/2008, Volume 112, Issue 10, pp. 3989 - 3994
Journal Article